Citation Impact

Citing Papers

Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Enhanced B-1 Cell Development, But Impaired IgG Antibody Responses in Mice Deficient in Secreted IgM
1998
AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
2007 StandoutNobel
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites
1988
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
2008 StandoutNature
The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?
2004
Cancer risk and oxidative DNA damage in man
1996
Muscle contractions induce interleukin‐6 mRNA production in rat skeletal muscles
2000
The effects of carbohydrate supplementation during the second of two prolonged cycling bouts on immunoendocrine responses
2005
Elevated Pyrogenic Cytokines in Heatstroke
1993
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults
1999
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
1993 Standout
Influence of Castration, Alone or Combined with Thymectomy, on the Development of Diabetes in the Nonobese Diabetic Mouse*
1991
Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling
2005
Interleukin-6 in Biology and Medicine
1993
Guillain-Barré syndrome
2016 Standout
Vitamin D and Multiple Sclerosis
1997
Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients
2002
Vitamin D Deficiency
2007 Standout
Sodium fusidate in Guillain-Barre syndrome: a case report
1998
Heat Stroke
2002 Standout
In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise
1997
Pro‐ and anti‐inflammatory cytokine balance in strenuous exercise in humans
1999
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Is Type II diabetes mellitus a disease of the innate immune system?
1998
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
2007
Osteoarthritis
2015 Standout
Interleukin 6 and its Receptor: Ten Years Later
1998
The role of interleukin‐6 in insulin resistance, body fat distribution and energy balance
2007
IL-6 as a keystone cytokine in health and disease
2015 Standout
Sarcoidosis
2013 Standout
Pentoxifylline in treatment of sarcoidosis.
1997
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Impact of elevated ambient temperatures on the acute immune response to intensive endurance exercise
2003
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Diabetes and Atherosclerosis
2002 Standout
Muscle‐derived interleukin‐6: possible biological effects
2001
Influence of mode and carbohydrate on the cytokine response to heavy exertion
1998
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis
1997
Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis
2013
Searching for the exercise factor: is IL-6 a candidate?
2003
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Exercise and hypoxia: effects on leukocytes and interleukin-6???shared mechanisms?
2002
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans
2000
Exercise‐induced increase in serum interleukin‐6 in humans is related to muscle damage.
1997
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis
2006
The CD4 lymphocyte count and risk of clinical progression
2006
Convergent Mechanisms for Recognition of Divergent Cytokines by the Shared Signaling Receptor gp130
2003 StandoutNobel
Interleukin‐6 and its receptor in cancer
2007
Perioperative Single-Dose Glucocorticoid Administration: Pathophysiologic Effects and Clinical Implications
2002
Autoimmunity and Apoptosis
2001 StandoutNobel
Interleukin-6 and its receptors: A highly regulated and dynamic system
2014
Evidence that interleukin‐6 is produced in human skeletal muscle during prolonged running
1998
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6
2000
Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects
2003
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Frailty in elderly people
2013 Standout
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
1992 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation
1996
Production of Interleukin-6 by Skeletal Myotubes
2002
Carbohydrate and the cytokine response to 2.5 h of running
1997
Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability
2004
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
2002
Exercise and the Immune System: Regulation, Integration, and Adaptation
2000
Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production
1995
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Exercise elevates plasma levels but not gene expression of IL-1β, IL-6, and TNF-α in blood mononuclear cells
2000
Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-α levels after prolonged running
2001
Interleukin-6 in acute exercise and training: what is the biological relevance?
2006
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Interleukin-6 response to exercise and high-altitude exposure: influence of α-adrenergic blockade
2001
N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise
2000
Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine.
1988 StandoutNobel
Inflammation and Atherosclerosis
2002 Standout
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
1998 Standout
Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6
1997
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
2001
DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.
1986
Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
1987
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
1997
Exercise and Toll-like receptors.
2006
Antioxidants attenuate the plasma cytokine response to exercise in humans
2003
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Dramatic Elevations of Interleukin-6 and Acute-Phase Reactants in Athletes Participating in the Ultradistance Foot Race Spartathlon: Severe Systemic Inflammation and Lipid and Lipoprotein Changes in Protracted Exercise
2005
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Interleukin-1 and interleukin-1 antagonism
1991 Standout
The anti-inflammatory effect of exercise
2005 Standout
Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia
2007
Effects of mode and carbohydrate on the granulocyte and monocyte response to intensive, prolonged exercise
1998
The Continuing Challenges of Leprosy
2006 Standout
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
1994

Works of Marcus Diamant being referenced

In VitroEffects of Human Growth Hormone on the Proliferative Responsesand Cytokine Production of Blood Mononuclear Cells
1994
Down-regulation of monocyte functions by treatment of healthy adults with 1α, 25 dihydroxyvitamin D3
1991
Increased mRNA expression and protein secretion of interleukin‐6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone
2001
Effects of an Acute Bolus Growth Hormone Infusion on the Human Immune System
1993
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin‐6 signal transducer gp1301
1997
Effect of Physical Exercise on In Vitro Production of Interleukin 1, Interleukin 6, Tumour Necrosis Factor-α, Interleukin 2 and Interferon-γ
1991
Effect of methylprednisolone on the cytokine response in patients undergoing lung surgery
1993
Influence of interleukin‐6 (IL‐6) autoantibodies on IL‐6 binding to cellular receptors
1995
Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3
1991
Restricted pulmonary diffusion capacity after exercise is not an ARDS‐like injury
1995
High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro
1993
Cytokine vaccination: neutralising IL-1α autoantibodies induced by immunisation with homologous IL-1α
2000
1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level
1992
Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A
1990
Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors
1996
In vitro immunomodulatory effects of pentoxifylline
1993
Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group.
1989
Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC
1994
The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons.
1994
Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate.
1985
Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumour necrosis factor-alpha and interferon-gamma.
1991
Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment.
1986
Antibody to Granulocyte-Macrophage Colony-Stimulating Factor Is a Dominant Anti-Cytokine Activity in Human IgG Preparations
1998
Rankless by CCL
2026